Publication: Characteristics and outcomes in primary aldosteronism patients harboring glucocorticoid-remediable aldosteronism
| cris.lastimport.scopus | 2025-05-09T22:28:09Z | |
| cris.virtual.department | Urology | en_US |
| cris.virtual.department | Urology-NTUH | en_US |
| cris.virtual.department | Internal Medicine | en_US |
| cris.virtual.department | Internal Medicine-NTUH | en_US |
| cris.virtual.department | Internal Medicine | en_US |
| cris.virtual.department | Internal Medicine-NTUH | en_US |
| cris.virtual.department | Medicine-NTUCC | en_US |
| cris.virtual.orcid | 0000-0002-0713-4904 | |
| cris.virtual.orcid | 0000-0001-8153-1441 | |
| cris.virtual.orcid | 0000-0001-7935-0991 | |
| cris.virtualsource.department | 82c82203-af01-450f-b44e-d187d634876f | |
| cris.virtualsource.department | 82c82203-af01-450f-b44e-d187d634876f | |
| cris.virtualsource.department | 0354e09d-bc4c-49f3-9d96-652375b0a17b | |
| cris.virtualsource.department | 0354e09d-bc4c-49f3-9d96-652375b0a17b | |
| cris.virtualsource.department | fb311a2e-86b1-46f6-911b-b8aa09ed9987 | |
| cris.virtualsource.department | fb311a2e-86b1-46f6-911b-b8aa09ed9987 | |
| cris.virtualsource.department | fb311a2e-86b1-46f6-911b-b8aa09ed9987 | |
| cris.virtualsource.orcid | 82c82203-af01-450f-b44e-d187d634876f | |
| cris.virtualsource.orcid | 0354e09d-bc4c-49f3-9d96-652375b0a17b | |
| cris.virtualsource.orcid | fb311a2e-86b1-46f6-911b-b8aa09ed9987 | |
| dc.contributor.author | Cheng C.-Y. | en_US |
| dc.contributor.author | Liao H.-W. | en_US |
| dc.contributor.author | Peng K.-Y. | en_US |
| dc.contributor.author | Chen T.-H. | en_US |
| dc.contributor.author | YEN-HUNG LIN | en_US |
| dc.contributor.author | SHIH-CHIEH CHUEH | en_US |
| dc.contributor.author | VIN-CENT WU | en_US |
| dc.contributor.author | TAIPAI Study Group | en_US |
| dc.date.accessioned | 2022-09-15T03:32:31Z | |
| dc.date.available | 2022-09-15T03:32:31Z | |
| dc.date.issued | 2021 | |
| dc.identifier.doi | 10.3390/biomedicines9121816 | |
| dc.identifier.issn | 2227-9059 | |
| dc.identifier.scopus | 2-s2.0-85121237583 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85121237583&doi=10.3390%2fbiomedicines9121816&partnerID=40&md5=9c30ebf7ead6efa3a000d7f54124c652 | |
| dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/620456 | |
| dc.publisher | MDPI | en_US |
| dc.relation.ispartof | Biomedicines | en_US |
| dc.relation.journalissue | 12 | en_US |
| dc.relation.journalvolume | 9 | en_US |
| dc.relation.pages | 1816 | en_US |
| dc.title | Characteristics and outcomes in primary aldosteronism patients harboring glucocorticoid-remediable aldosteronism | en_US |
| dc.type | journal article | en |
| dspace.entity.type | Publication |